Evaluating the use of a theory-based intervention to improve medication-taking behaviours: A Longitudinal mixed-methods study in patients with Pulmonary Arterial Hypertension. Applying Health Belief Model theory to understand patients’ medication and disease beliefs and using this to develop and evaluate targeted interventions delivered by a pharmacist to improve medication adherence

Description

Pulmonary Arterial Hypertension (PAH) is a rare incurable condition affecting both the cardiac and respiratory systems. Patients living with PAH face the burden of both intensive medication regimens and debilitating disease symptoms. This study’s primary aim was to identify patients’ medication-taking behaviours and beliefs using a framework derived from the extended health belief model (EHBM), and to use this information to deliver personalised interventions to improve medication-taking behaviours. A
mixed-methodology longitudinal study design recorded patients’ parameters
over a 12-month period. Thirteen participants from Northern Ireland
completed the study. The results showed that the level of high-adherence to
PAH medicines, as assessed using the MARS questionnaire was 80%, but
this value differed when assessed via pill counting and interview data. There was a trend to improvement in observed and predicted medication adherence over the study duration. Participants’ beliefs showed a non-statistical increase in the specific-necessity beliefs and a reduction in
general-overuse belief. This study added to the EHBM new constructs of trust and support in being able to better predict nonadherent behaviours. Key medication-taking themes were self-confidence, perceived ranking of medicines, uncertainty and knowledge. This study developed important
learning that can be applied to future research on behavioural health studies. / Heart Trust Fund;
Actelion Pharmaceuticals

Links & Downloads

1. http://hdl.handle.net/10454/19218

Tags

Belief

Adherence

Medication

Complience

Health Belief Model

Behaviour

Intervention

Education

Pulmonary Arterial Hypertension (PAH)

Parmacist interventions

Patients

Pharmacists

Additional Fields

Identifer	oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/19218
Date	January 2020
Creators	Jackson, Michael P.
Contributors	Morgan, Julie D., Quinn, Gemma L., Palmer, Timothy M.
Publisher	University of Bradford, Faculty of Life Sciences School of Pharmacy and Medical Sciences
Source Sets	Bradford Scholars
Language	English
Detected Language	English
Type	Thesis, doctoral, PharmD
Rights	<a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>.